반응식
[NH:1]1[CH2:6][CH2:5][C:4]([C:7]2[CH:12]=[CH:11][C:10]([N:13]3[CH2:17][C@H:16]([CH2:18][NH:19][C:20](=[O:22])[CH3:21])[O:15][C:14]3=[O:23])=[CH:9][CH:8]=2)=[CH:3][CH2:2]1.[C:24]([CH:28]1[CH2:33][CH2:32][CH:31]([C:34](O)=[O:35])[CH2:30][CH2:29]1)([CH3:27])([CH3:26])[CH3:25]>>[C:24]([CH:28]1[CH2:29][CH2:30][CH:31]([C:34]([N:1]2[CH2:6][CH2:5][C:4]([C:7]3[CH:12]=[CH:11][C:10]([N:13]4[CH2:17][C@H:16]([CH2:18][NH:19][C:20](=[O:22])[CH3:21])[O:15][C:14]4=[O:23])=[CH:9][CH:8]=3)=[CH:3][CH2:2]2)=[O:35])[CH2:32][CH2:33]1)([CH3:27])([CH3:25])[CH3:26]참가 물질
3
실험 절차
Using an analogous procedure to that described in Example 20, the TFA salt of Example 2 was reacted with 4-tert-butylcyclohexanecarboxylic acid in place of Acetylglycine, to give the title compound. Yield=208 mg, 58%.
출처 및 근거
- ORD 기록
- ord-227f1e700b3941828193971444e0ccbf
- 출처 데이터셋
- uspto-grants-2002_04
- 특허 번호
- US06365751B1
연결된 노트
불러오는 중…